Biovica International AB (publ) reported earnings results for the second quarter and six months ended October 31, 2023. For the second quarter, the company reported sales was SEK 2.56 million compared to SEK 1.35 million a year ago. Revenue was SEK 2.59 million compared to SEK 1.46 million a year ago. Net loss was SEK 25.68 million compared to SEK 23.25 million a year ago. Basic loss per share from continuing operations was SEK 0.56 compared to SEK 0.81 a year ago. Diluted loss per share from continuing operations was SEK 0.56 compared to SEK 0.81 a year ago.
For the six months, sales was SEK 4.32 million compared to SEK 2.34 million a year ago. Revenue was SEK 4.92 million compared to SEK 2.56 million a year ago. Net loss was SEK 57.95 million compared to SEK 44.25 million a year ago. Basic loss per share from continuing operations was SEK 1.27 compared to SEK 1.55 a year ago. Diluted loss per share from continuing operations was SEK 1.27 compared to SEK 1.55 a year ago.